GlassScriptPhysician profile
Luz E Pacheco
NPI 1982824769
$1,675.99
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $966 · 2022: $559 · 2023: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $323.64 | 2021-2022 | |
| Abbvie INC. | $311.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $137.68 | 2021-2022 | |
| Optinose US, INC. | $125.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $124.98 | 2023 | Evkeeza |
| Janssen Pharmaceuticals, INC | $108.89 | 2022 | |
| Sanofi-Aventis U.S. LLC | $104.63 | 2021 | |
| Lilly USA, LLC | $79.44 | 2021-2022 | |
| Dexcom, INC. | $64.30 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $36.62 | 2022 | |
| Merz North America, INC. | $25.85 | 2023 | Xeomin |
| Biohaven Pharmaceutical Holding Company LTD. | $24.37 | 2022 | |
| Amarin Pharma, INC. | $23.78 | 2021 | |
| Pfizer INC. | $21.12 | 2022 | |
| Daiichi Sankyo INC. | $20.35 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.01 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.01 | 2022 | |
| Novo Nordisk INC | $17.86 | 2021 | |
| Astellas Pharma US INC | $17.33 | 2021 | |
| Esperion Therapeutics, INC. | $16.76 | 2021 | |
| Amgen INC. | $15.79 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2022 | |
| Currax Pharmaceuticals LLC | $13.27 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luz Pacheco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.